Precigen, Inc. Average Common Equity

Average Common Equity of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Average Common Equity growth rates and interactive chart.


Highlights and Quick Summary

  • Average Common Equity for the quarter ending March 31, 2022 was $124 Million (a 42.46% increase compared to previous quarter)
  • Year-over-year quarterly Average Common Equity increased by 19.11%
  • Annual Average Common Equity for 2021 was $87.3 Million (a 25.66% increase from previous year)
  • Annual Average Common Equity for 2020 was $69.4 Million (a -68.04% decrease from previous year)
  • Annual Average Common Equity for 2019 was $217 Million (a -51.53% decrease from previous year)
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Average Common Equity of Precigen, Inc.

Most recent Average Common Equityof PGEN including historical data for past 10 years.

Interactive Chart of Average Common Equity of Precigen, Inc.

Precigen, Inc. Average Common Equity for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $124.32
2021 $87.26 $94.9 $104.37 $131.01 $87.26
2020 $69.44 $143.49 $164.38 $211.03 $69.44
2019 $225.22 $391.93 $423.18 $484.47 $217.28
2018 $462.63 $554.31 $569.35 $592.14 $448.24
2017 $557.9 $580.8 $599.87 $612.5 $551.44
2016 $637.07 $669.02 $557.55 $664.09 $637.07
2015 $557.09 $554.73 $437.65 $542.62 $557.09
2014 $395.32 $385.53 $13.42 $105.32 $395.32
2013 $395.32 $385.53 $13.42 $29.9
2012 $-271.41
2011 $105.32 $-271.41

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology